Cargando…
Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative Patients
BACKGROUND: To assess and compare the prevalence, severity and prognosis of anti-TB drug induced hepatotoxicity (DIH) in HIV positive and HIV negative tuberculosis (TB) patients in Ethiopia. METHODOLOGY/PRINCIPAL FINDINGS: In this study, 103 HIV positive and 94 HIV negative TB patients were enrolled...
Autores principales: | Yimer, Getnet, Aderaye, Getachew, Amogne, Wondwossen, Makonnen, Eyasu, Aklillu, Eleni, Lindquist, Lars, Yamuah, Lawrence, Feleke, Beniyam, Aseffa, Abraham |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265547/ https://www.ncbi.nlm.nih.gov/pubmed/18350147 http://dx.doi.org/10.1371/journal.pone.0001809 |
Ejemplares similares
-
Evaluation of Patterns of Liver Toxicity in Patients on Antiretroviral and Anti-Tuberculosis Drugs: A Prospective Four Arm Observational Study in Ethiopian Patients
por: Yimer, Getnet, et al.
Publicado: (2014) -
Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial
por: Amogne, Wondwossen, et al.
Publicado: (2015) -
Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients
por: Yimer, Getnet, et al.
Publicado: (2011) -
Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity
por: Petros, Zelalem, et al.
Publicado: (2016) -
HLA-B(*)57 Allele Is Associated with Concomitant Anti-tuberculosis and Antiretroviral Drugs Induced Liver Toxicity in Ethiopians
por: Petros, Zelalem, et al.
Publicado: (2017)